Skip Navigation

Bone marrow-derived multidrug resistance protein ABCB4 protects against atherosclerotic lesion development in LDL receptor knockout mice

  1. Marieke Penningsa,*,
  2. Reeni B. Hildebranda,
  3. Dan Yea,
  4. Cindy Kunneb,
  5. Theo J.C. Van Berkela,
  6. Albert K. Groenb and
  7. Miranda Van Ecka
  1. aDivision of Biopharmaceutics, Leiden/Amsterdam Center for Drug Research, Leiden University, Einsteinweg 55, 2333 CC Leiden, The Netherlands
  2. bDepartment of Medical Biochemistry, Amsterdam Medical Center, Meibergdreef 15, 1105 BK Amsterdam, The Netherlands
  1. *
    Corresponding author. Einsteinweg 55, 2333 CC Leiden, The Netherlands. Tel.: +31 715276213; fax: + 31 715276032. pennings{at}lacdr.leidenuniv.nl
  • Received November 16, 2006.
  • Revision requested May 9, 2007.
  • Accepted May 11, 2007.

Abstract

Objective Several members of the ATP binding cassette (ABC)-transporter super family expressed in macrophages protect against atherosclerosis by promoting macrophage cholesterol and phospholipid efflux. Systemic disruption of ABCB4 in mice results in a virtual absence of phospholipids in bile and a strongly impaired biliary cholesterol secretion, indicating that ABCB4 plays an essential role in cellular lipid efflux. The aim of the current study was to determine the role of bone marrow-derived ABCB4 in atherosclerotic lesion development.

Methods Chimeras were created that specifically lack ABCB4 in bone marrow-derived cells, including macrophages, by performing a bone marrow transplantation on LDL receptor knockout (LDLr−/−) mice. Atherosclerotic lesion development was induced by feeding a high-cholesterol diet (15% fat and 0.25% cholesterol).

Results Serum cholesterol levels were significantly lower in mice reconstituted with ABCB4 knockout bone marrow as a result of reduced VLDL and LDL cholesterol levels. Despite the lower serum cholesterol levels, ABCB4 deficiency in bone marrow-derived cells resulted in a 1.8-fold (p=0.005) increase in lesion size. In vitro foam cell formation, induced with acetylated LDL (AcLDL) in peritoneal macrophages, was increased in the absence of ABCB4, possibly due to a 2-fold (p<0.05) increased association of AcLDL, while the efflux of cholesterol was unaffected.

Conclusion Bone marrow-derived ABCB4 has an important anti-atherosclerotic function, probably by limiting macrophage foam cell formation.

Keywords

Key words

    « Previous | Next Article »Table of Contents

    This Article

    1. Cardiovasc Res (2007) 76 (1): 175-183. doi: 10.1016/j.cardiores.2007.05.016
    1. » AbstractFree
    2. Full Text (HTML)Free
    3. Full Text (PDF)Free

    Classifications

    Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. April 1, 2010, 86 (1)
    1. Current Issue
    1. Alert me to new issues

    Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.